List of Tables
Table 1. Global Primary Immunodeficiency Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Primary Immunodeficiency Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Primary Immunodeficiency Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Primary Immunodeficiency Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Primary Immunodeficiency Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Primary Immunodeficiency Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Primary Immunodeficiency Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Primary Immunodeficiency Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Primary Immunodeficiency Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Primary Immunodeficiency Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Primary Immunodeficiency Drug, Product Type & Application
Table 12. Global Key Manufacturers of Primary Immunodeficiency Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Primary Immunodeficiency Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Immunodeficiency Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Immunodeficiency Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Primary Immunodeficiency Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Primary Immunodeficiency Drug Sales Market Share by Region (2020-2025)
Table 19. Global Primary Immunodeficiency Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Primary Immunodeficiency Drug Sales Market Share by Region (2026-2031)
Table 21. Global Primary Immunodeficiency Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Primary Immunodeficiency Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Primary Immunodeficiency Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Primary Immunodeficiency Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Primary Immunodeficiency Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Primary Immunodeficiency Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Primary Immunodeficiency Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Primary Immunodeficiency Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Primary Immunodeficiency Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Primary Immunodeficiency Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Primary Immunodeficiency Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Primary Immunodeficiency Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Primary Immunodeficiency Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Primary Immunodeficiency Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Primary Immunodeficiency Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Primary Immunodeficiency Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Primary Immunodeficiency Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Primary Immunodeficiency Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Primary Immunodeficiency Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Immunodeficiency Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Primary Immunodeficiency Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Primary Immunodeficiency Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Primary Immunodeficiency Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Primary Immunodeficiency Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Primary Immunodeficiency Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Primary Immunodeficiency Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Primary Immunodeficiency Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Primary Immunodeficiency Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Primary Immunodeficiency Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Primary Immunodeficiency Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Primary Immunodeficiency Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Primary Immunodeficiency Drug Sales Market Share by Type (2020-2025)
Table 53. Global Primary Immunodeficiency Drug Sales Market Share by Type (2026-2031)
Table 54. Global Primary Immunodeficiency Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Primary Immunodeficiency Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Primary Immunodeficiency Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Primary Immunodeficiency Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Primary Immunodeficiency Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Primary Immunodeficiency Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Primary Immunodeficiency Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Primary Immunodeficiency Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Primary Immunodeficiency Drug Sales Market Share by Application (2020-2025)
Table 63. Global Primary Immunodeficiency Drug Sales Market Share by Application (2026-2031)
Table 64. Global Primary Immunodeficiency Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Primary Immunodeficiency Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Primary Immunodeficiency Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Primary Immunodeficiency Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Primary Immunodeficiency Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Primary Immunodeficiency Drug Price (US$/Unit) by Application (2026-2031)
Table 70. ADMA Biologics, Inc. Company Information
Table 71. ADMA Biologics, Inc. Description and Business Overview
Table 72. ADMA Biologics, Inc. Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. ADMA Biologics, Inc. Primary Immunodeficiency Drug Product
Table 74. ADMA Biologics, Inc. Recent Developments/Updates
Table 75. CSL Behring, LLC Company Information
Table 76. CSL Behring, LLC Description and Business Overview
Table 77. CSL Behring, LLC Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CSL Behring, LLC Primary Immunodeficiency Drug Product
Table 79. CSL Behring, LLC Recent Developments/Updates
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Octapharma Primary Immunodeficiency Drug Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Takeda Pharmaceutical Company Company Information
Table 86. Takeda Pharmaceutical Company Description and Business Overview
Table 87. Takeda Pharmaceutical Company Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Pharmaceutical Company Primary Immunodeficiency Drug Product
Table 89. Takeda Pharmaceutical Company Recent Developments/Updates
Table 90. Grifols Biologicals, Inc. Company Information
Table 91. Grifols Biologicals, Inc. Description and Business Overview
Table 92. Grifols Biologicals, Inc. Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Grifols Biologicals, Inc. Primary Immunodeficiency Drug Product
Table 94. Grifols Biologicals, Inc. Recent Developments/Updates
Table 95. Baxter Company Information
Table 96. Baxter Description and Business Overview
Table 97. Baxter Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Baxter Primary Immunodeficiency Drug Product
Table 99. Baxter Recent Developments/Updates
Table 100. Kedrion Biopharma Company Information
Table 101. Kedrion Biopharma Description and Business Overview
Table 102. Kedrion Biopharma Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Kedrion Biopharma Primary Immunodeficiency Drug Product
Table 104. Kedrion Biopharma Recent Developments/Updates
Table 105. BPL Inc. Company Information
Table 106. BPL Inc. Description and Business Overview
Table 107. BPL Inc. Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPL Inc. Primary Immunodeficiency Drug Product
Table 109. BPL Inc. Recent Developments/Updates
Table 110. Pharming Group Company Information
Table 111. Pharming Group Description and Business Overview
Table 112. Pharming Group Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pharming Group Primary Immunodeficiency Drug Product
Table 114. Pharming Group Recent Developments/Updates
Table 115. Shire Company Information
Table 116. Shire Description and Business Overview
Table 117. Shire Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shire Primary Immunodeficiency Drug Product
Table 119. Shire Recent Developments/Updates
Table 120. Chengdu Rongsheng Pharmaceutical Co., Ltd Company Information
Table 121. Chengdu Rongsheng Pharmaceutical Co., Ltd Description and Business Overview
Table 122. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Chengdu Rongsheng Pharmaceutical Co., Ltd Primary Immunodeficiency Drug Product
Table 124. Chengdu Rongsheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Primary Immunodeficiency Drug Distributors List
Table 128. Primary Immunodeficiency Drug Customers List
Table 129. Primary Immunodeficiency Drug Market Trends
Table 130. Primary Immunodeficiency Drug Market Drivers
Table 131. Primary Immunodeficiency Drug Market Challenges
Table 132. Primary Immunodeficiency Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Primary Immunodeficiency Drug
Figure 2. Global Primary Immunodeficiency Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Immunodeficiency Drug Market Share by Type: 2024 & 2031
Figure 4. Immunoglobulin Product Picture
Figure 5. Antibiotic Product Picture
Figure 6. Stem Cell Product Picture
Figure 7. Other Product Picture
Figure 8. Global Primary Immunodeficiency Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Primary Immunodeficiency Drug Market Share by Application: 2024 & 2031
Figure 10. Antibody Deficiency
Figure 11. Cellular Immunodeficiency
Figure 12. Innate Immune Disease
Figure 13. Other
Figure 14. Global Primary Immunodeficiency Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Primary Immunodeficiency Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Primary Immunodeficiency Drug Sales (2020-2031) & (K Units)
Figure 17. Global Primary Immunodeficiency Drug Average Price (US$/Unit) & (2020-2031)
Figure 18. Primary Immunodeficiency Drug Report Years Considered
Figure 19. Primary Immunodeficiency Drug Sales Share by Manufacturers in 2024
Figure 20. Global Primary Immunodeficiency Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Primary Immunodeficiency Drug Players: Market Share by Revenue in Primary Immunodeficiency Drug in 2024
Figure 22. Primary Immunodeficiency Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Primary Immunodeficiency Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Primary Immunodeficiency Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Primary Immunodeficiency Drug Revenue Market Share by Country (2020-2031)
Figure 26. United States Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Primary Immunodeficiency Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Primary Immunodeficiency Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Primary Immunodeficiency Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Primary Immunodeficiency Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Primary Immunodeficiency Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Primary Immunodeficiency Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Primary Immunodeficiency Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Primary Immunodeficiency Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Primary Immunodeficiency Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Primary Immunodeficiency Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Primary Immunodeficiency Drug by Type (2020-2031)
Figure 58. Global Primary Immunodeficiency Drug Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Primary Immunodeficiency Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Primary Immunodeficiency Drug by Application (2020-2031)
Figure 61. Global Primary Immunodeficiency Drug Price (US$/Unit) by Application (2020-2031)
Figure 62. Primary Immunodeficiency Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
